Amesite Launches Census-Based Enterprise Tier for NurseMagic™ to Drive Revenue Growth and Meet Enterprise Demand, Significantly Expanding Total Addressable Market
Amesite (NASDAQ: AMST) has launched NurseMagic™ Enterprise Tier, an advanced AI-powered solution for post-acute healthcare providers. The new tier introduces three key features: seamless EMR integration with bi-directional data transfer, automated interdisciplinary team (IDT) reporting, and custom-formatted documentation support.
A significant change in the business model introduces census-based pricing, aligning costs with patient numbers rather than staff count. This strategic shift aims to facilitate enterprise-wide adoption and scalable revenue growth. The company will discontinue new sales of its entry-level B2B Teams plan, focusing on Teams Plus+ for smaller organizations and the new Enterprise Tier for larger-scale deployments.
NurseMagic™ currently operates across all 50 U.S. states and 21 countries, positioning Amesite to capture greater market share in the post-acute enterprise market.Amesite (NASDAQ: AMST) ha lanciato NurseMagic™ Enterprise Tier, una soluzione avanzata potenziata dall'intelligenza artificiale dedicata ai fornitori di servizi sanitari post-acuti. Il nuovo livello introduce tre funzionalità principali: integrazione fluida con EMR con trasferimento dati bidirezionale, reportistica automatizzata per team interdisciplinari (IDT) e supporto per documentazione personalizzata.
Un cambiamento significativo nel modello di business introduce una tariffazione basata sul censimento, allineando i costi al numero di pazienti anziché al numero di personale. Questa strategia mira a facilitare l'adozione a livello aziendale e una crescita scalabile dei ricavi. L'azienda interromperà le nuove vendite del piano B2B Teams entry-level, concentrandosi su Teams Plus+ per organizzazioni più piccole e sul nuovo Enterprise Tier per implementazioni su larga scala.
NurseMagic™ è attualmente operativo in tutti i 50 stati degli USA e in 21 paesi, posizionando Amesite per conquistare una quota di mercato maggiore nel settore post-acuto aziendale.
Amesite (NASDAQ: AMST) ha lanzado NurseMagic™ Enterprise Tier, una solución avanzada impulsada por IA para proveedores de atención sanitaria post-aguda. El nuevo nivel presenta tres características clave: integración fluida con EMR con transferencia de datos bidireccional, informes automatizados para equipos interdisciplinarios (IDT) y soporte para documentación personalizada.
Un cambio importante en el modelo de negocio introduce una tarificación basada en el censo, alineando los costos con el número de pacientes en lugar del personal. Este cambio estratégico busca facilitar la adopción a nivel empresarial y un crecimiento escalable de ingresos. La empresa dejará de vender su plan B2B Teams de nivel básico, enfocándose en Teams Plus+ para organizaciones más pequeñas y en el nuevo Enterprise Tier para implementaciones a gran escala.
NurseMagic™ opera actualmente en los 50 estados de EE.UU. y en 21 países, posicionando a Amesite para capturar una mayor cuota de mercado en el sector post-agudo empresarial.
Amesite (NASDAQ: AMST)는 급성기 이후 의료 제공자를 위한 고급 AI 기반 솔루션인 NurseMagic™ Enterprise Tier를 출시했습니다. 새로운 티어는 세 가지 주요 기능을 도입합니다: 양방향 데이터 전송이 가능한 원활한 EMR 통합, 자동화된 다학제 팀(IDT) 보고, 맞춤형 문서 지원입니다.
비즈니스 모델에 중요한 변화로 환자 수 기반 가격 책정을 도입하여 비용을 직원 수가 아닌 환자 수에 맞추었습니다. 이 전략적 변화는 기업 전반의 도입과 확장 가능한 수익 성장을 촉진하는 것을 목표로 합니다. 회사는 엔트리 레벨 B2B Teams 플랜의 신규 판매를 중단하고, 소규모 조직을 위한 Teams Plus+와 대규모 배포를 위한 새로운 Enterprise Tier에 집중할 예정입니다.
NurseMagic™는 현재 미국 50개 주 전역과 21개국에서 운영되고 있어 Amesite가 급성기 이후 기업 시장에서 더 큰 시장 점유율을 확보할 수 있는 위치에 있습니다.
Amesite (NASDAQ : AMST) a lancé NurseMagic™ Enterprise Tier, une solution avancée alimentée par l'IA destinée aux prestataires de soins post-aigus. Ce nouveau niveau introduit trois fonctionnalités clés : une intégration transparente avec les dossiers médicaux électroniques (EMR) avec transfert bidirectionnel des données, des rapports automatisés pour les équipes interdisciplinaires (IDT) et un support pour la documentation personnalisée.
Un changement majeur dans le modèle commercial introduit une tarification basée sur le nombre de patients, alignant les coûts sur le nombre de patients plutôt que sur le nombre de membres du personnel. Cette stratégie vise à faciliter l'adoption à l'échelle de l'entreprise et à favoriser une croissance des revenus évolutive. La société cessera les nouvelles ventes de son plan B2B Teams d'entrée de gamme, en se concentrant sur Teams Plus+ pour les petites organisations et sur le nouveau Enterprise Tier pour les déploiements à grande échelle.
NurseMagic™ est actuellement utilisé dans les 50 états américains et 21 pays, positionnant Amesite pour accroître sa part de marché dans le secteur post-aigu d'entreprise.
Amesite (NASDAQ: AMST) hat NurseMagic™ Enterprise Tier eingeführt, eine fortschrittliche KI-gestützte Lösung für Anbieter im post-akuten Gesundheitswesen. Die neue Stufe bietet drei Hauptfunktionen: nahtlose EMR-Integration mit bidirektionalem Datenaustausch, automatisierte Berichterstattung für interdisziplinäre Teams (IDT) und Unterstützung für individuell formatierte Dokumentationen.
Eine wesentliche Änderung im Geschäftsmodell führt eine preisgestaltung basierend auf der Patientenzahl ein, die die Kosten an die Anzahl der Patienten statt an die Mitarbeiterzahl anpasst. Dieser strategische Wandel zielt darauf ab, eine unternehmensweite Einführung und skalierbares Umsatzwachstum zu ermöglichen. Das Unternehmen wird den Verkauf seines Einstiegs-B2B-Teams-Plans einstellen und sich auf Teams Plus+ für kleinere Organisationen sowie das neue Enterprise Tier für groß angelegte Einsätze konzentrieren.
NurseMagic™ ist derzeit in allen 50 US-Bundesstaaten und 21 Ländern aktiv, was Amesite eine stärkere Marktposition im post-akuten Unternehmensmarkt verschafft.
- New census-based pricing model aligns with healthcare provider growth and revenue potential
- Expanded market reach with presence in all 50 U.S. states and 21 countries
- Enhanced enterprise features including EMR integration and automated IDT reporting
- Strategic focus on higher-value enterprise customers through tier consolidation
- Discontinuation of entry-level B2B Teams plan may impact smaller potential customers
- Success depends on healthcare providers' willingness to adopt new pricing model
Insights
Amesite's new NurseMagic Enterprise Tier with census-based pricing and EMR integration expands revenue potential in post-acute care market.
Amesite's launch of the NurseMagic Enterprise Tier represents a strategic product evolution targeting larger healthcare organizations with census-based pricing rather than per-user models. This approach aligns with healthcare economics where revenue scales with patient volume, not staff count.
The new tier addresses three critical pain points in post-acute care: EMR integration for seamless documentation workflow, automated IDT reporting for compliance efficiency, and custom documentation support for billing requirements. These features directly target labor-intensive processes that burden clinical staff.
By pivoting from headcount-based to census-based pricing, Amesite creates a more sustainable revenue model with built-in growth potential as client organizations expand patient loads. This model also eliminates adoption friction at large organizations where per-user pricing often creates budgetary resistance.
The company's discontinuation of its entry-level B2B Teams plan in favor of Teams Plus+ and Enterprise tiers signals confidence in their ability to capture higher average revenue per customer. This product tier consolidation reflects a maturing solution capable of commanding premium pricing.
While no specific revenue projections were provided, the expanded features and enterprise positioning could significantly increase Amesite's deal sizes in the post-acute market. The company's current presence across all 50 states and 21 countries provides an established distribution channel for this enhanced offering.
The introduction of NurseMagic Enterprise Tier reveals Amesite's strategic shift toward enterprise monetization after initially building traction with individual practitioners. This follows the classic SaaS expansion playbook of land-and-expand: start with individual users, move to small teams, then capture enterprise-wide contracts.
The census-based pricing model represents a significant advancement in Amesite's revenue potential. Traditional per-seat pricing often undermonetizes healthcare organizations where a small staff may serve hundreds of patients. By aligning pricing with patient census instead of user count, Amesite can capture value proportional to the actual business impact they deliver.
The product strategy of discontinuing the entry-level B2B Teams plan while maintaining Teams Plus+ and adding Enterprise indicates Amesite is optimizing for higher contract values rather than customer count. This typically increases average revenue per account (ARPA) while reducing customer acquisition costs relative to lifetime value.
The introduction of EMR integration capabilities opens access to larger healthcare systems where interoperability is a non-negotiable requirement. This development removes a common enterprise adoption barrier and positions NurseMagic to compete for contracts previously inaccessible to standalone documentation tools.
While specific revenue projections weren't disclosed, census-based pricing models typically produce more predictable, growing revenue streams as they automatically adjust with the customer's business volume. For investors, this model creates a more resilient SaaS business with built-in expansion revenue from existing customers.
New Tier Adds EMR Integration, Team Reporting (IDT) and Custom Form Support — Enabling Scalable Deployment Across Entire Patient Census
DETROIT, July 14, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered enterprise solutions, today announced the launch of the new NurseMagic™ Enterprise Tier, built to meet the most urgent needs of mid- and large-scale post-acute healthcare providers. Developed in direct response to customer demand, NurseMagic™ Enterprise integrates advanced, AI-powered capabilities into existing workflows — seamlessly and compliantly. By aligning pricing with patient census, Amesite believes this offering significantly increases its addressable market and supports long-term revenue growth.
NurseMagic™ Enterprise includes:
- Seamless EMR integration. NurseMagic™ Enterprise enables bi-directional data transfer and connectivity with electronic medical records (EMRs), allowing documentation created in NurseMagic™ Enterprise to populate directly into clinical systems. This integration is designed to fit seamlessly into existing workflows — preserving continuity for staff while delivering unparalleled documentation efficiency.
- Automated interdisciplinary team (IDT) reporting. NurseMagic™ now generates formatted IDT reports automatically, streamlining one of the most time-intensive compliance processes for home health and hospice agencies. This feature is built to operate within current team structures — saving time without requiring teams to change how they work.
- Custom-formatted documentation for compliance and billing. NurseMagic™ Enterprise supports customer-specific templates for documentation required by payers, regulators, and internal teams. This assures that providers can continue to use their own established forms — now generated faster and with greater consistency with NurseMagic™’s powerful, proprietary AI tools.
- Census-based pricing that scales with care delivery. By tying pricing to patient census rather than staff count, NurseMagic™ enables organizations to deploy across full care teams with clarity and control. This model supports growth without operational disruption — and positions Amesite to capture revenue as census expands.
Brandon Owens, Vice President of Sales at Amesite, said, “Tying our pricing to patient census — rather than headcount — allows us to scale revenue in alignment with how our customers scale care. We believe this model unlocks significantly more opportunity by eliminating friction that limits full enterprise adoption. Providers with lean teams and large patient loads now have a clear path to full deployment. NurseMagic™ grows with them, capturing more value as they scale. This approach reflects how care is delivered and monetized in real-world settings.”
Kalie Wortinger, Senior Engineering Manager at Amesite, said, “NurseMagic™ Enterprise was engineered to support providers delivering care at scale. Providers in home health, hospice, and skilled nursing have told us they need flexible solutions that work across entire teams. With seamless EMR integration, IDT automation, and support for custom documentation formats, NurseMagic™ Enterprise meets the operational and compliance demands of enterprise-scale healthcare.”
Dr. Ann Marie Sastry, Chief Executive Officer of Amesite, said, “Amesite built NurseMagic™ by starting with individual nurses, then validating performance across dozens of organizations, and now methodically expanding capabilities to meet large-scale enterprise needs. We believe we’re uniquely positioned to win in both B2B and B2C markets. Individual nurses can still onboard instantly with a credit card, while enterprise customers now have access to a configurable, integrated solution that supports agency-wide efficiency. With NurseMagic™ Enterprise, we’re executing on our ambition to deliver system-level impact and capture the full value of the post-acute market. We believe that this is an essential component of how we scale recurring revenue and build a category-defining solution for enterprise healthcare.”
With the launch of NurseMagic™ Enterprise, Amesite will discontinue new sales of its entry-level B2B Teams plan. Going forward, B2B customers will choose between Teams Plus+, intended for organizations with smaller patient censuses, and the new NurseMagic™ Enterprise Tier, which supports larger-scale deployment and full-agency efficiency. Existing Teams customers will continue to be supported. Amesite believes that consolidating around these two enhanced tiers enables the Company to capture more value from each organization served and positions it to drive stronger recurring revenue growth.
This announcement follows a series of recent enhancements, including the Teams Plus+ premium tier, multilingual capabilities, and expanded functionality supporting both clinical and non-clinical roles. NurseMagic™ is currently used across all 50 U.S. states and 21 countries, and Amesite remains focused on delivering rapid product cycles, secure AI infrastructure, and sustained growth in the post-acute enterprise market.
About Amesite Inc.
Amesite (NASDAQ: AMST) is an AI-driven company with an immediate aim to transform the
Forward-Looking Statements
This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations
ir@amesite.com
FAQ
What new features does Amesite's NurseMagic Enterprise Tier (NASDAQ: AMST) include?
How does Amesite's new census-based pricing model work for NurseMagic?
What is replacing Amesite's B2B Teams plan for NurseMagic?
Where is Amesite's NurseMagic currently available?
How does NurseMagic Enterprise integrate with existing healthcare systems?
